Archive
Year
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
Atezolizumab plus nabpaclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
LANCET ONCOLOGY
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 12
Presenting symptoms of cancer and stage at diagnosis: Evidence from a cross-sectional, population-based study
View 27